Mayo Clinic Gets FDA Approval for New Imaging Agent for Recurrent Prostate Cancer
Thursday, November 8, 2012 - 14:00
in Health & Medicine
Mayo Clinic has received U.S. Food and Drug Administration approval to produce and administer Choline C 11 Injection, an imaging agent used during a positron emission tomography (PET) scan to help detect sites of recurrent prostate cancer.